- Home
- Publications
- Publication Search
- Publication Details
Title
Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 30, Issue 2, Pages 229-231
Publisher
Informa Healthcare
Online
2013-10-16
DOI
10.1185/03007995.2013.855192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statins in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Updated Review
- (2013) William Nseir et al. Current Atherosclerosis Reports
- Statins and nonalcoholic fatty liver disease: a bright future?
- (2013) Vasilios G Athyros et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Atorvastatin Active Metabolite Inhibits Oxidative Modification of Small Dense Low-Density Lipoprotein
- (2013) Robert F. Jacob et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
- (2012) Vassilios G. Athyros et al. Archives of Medical Science
- The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease
- (2012) Luis E. Simental-Mendía et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study
- (2012) Teruki Miyake et al. JOURNAL OF GASTROENTEROLOGY
- Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
- (2012) Hemant Chatrath et al. SEMINARS IN LIVER DISEASE
- Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
- (2011) Vasilios G. Athyros et al. ANNALS OF MEDICINE
- NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
- (2011) Veerle Bieghs et al. ATHEROSCLEROSIS
- Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women
- (2011) Vassilios G. Athyros et al. Current Vascular Pharmacology
- “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Pleiotropic Effects of Statins - Clinical Evidence
- (2009) Vasilios Athyros et al. CURRENT PHARMACEUTICAL DESIGN
- Do we need to consider inflammatory markers when we treat atherosclerotic disease?
- (2008) Vasilios G. Athyros et al. ATHEROSCLEROSIS
- The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects
- (2008) Ki Chul Sung et al. ATHEROSCLEROSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started